English  |  正體中文  |  简体中文  |  0  
???header.visitor??? :  53158028    ???header.onlineuser??? :  658
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"kao s"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 1-25 of 43  (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2022-09-15T01:09:04Z Lorlatinib in advanced ROS1-positive non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 1–2 trial Shaw A.T.; Solomon B.J.; Chiari R.; Riely G.J.; Besse B.; Soo R.A.; Kao S.; Chia-Chi Lin; Bauer T.M.; Clancy J.S.; Thurm H.; Martini J.-F.; Peltz G.; Abbattista A.; Li S.; Ou S.-H.I.
臺大學術典藏 2022-09-15T01:08:57Z Impact of lorlatinib on patient-reported outcomes in patients with advanced ALK-positive or ROS1-positive non-small cell lung cancer Peters S.; Shaw A.T.; Besse B.; Felip E.; Solomon B.J.; Soo R.A.; Bearz A.; Gadgeel S.M.; Chia-Chi Lin; Kao S.; Seto T.; Masters E.T.; Abbattista A.; Clancy J.S.; Thurm H.; Reisman A.; Peltz G.; Ross Camidge D.
國立成功大學 2022 Licogliflozin for nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a study Harrison, S.A.;Manghi, F.P.;Smith, W.B.;Alpenidze, D.;Aizenberg, D.;Klarenbeek, N.;Chen, Chen C.-Y.;Zuckerman, E.;Ravussin, E.;Charatcharoenwitthaya, P.;Cheng, P.-N.;Katchman, H.;Klein, S.;Ben-Ari, Z.;Mendonza, A.E.;Zhang, Y.;Martic, Martic M.;Ma, S.;Kao, S.;Tanner, S.;Pachori, A.;Badman, M.K.;He, Y.L.;Ukomadu, C.;Sicard, E.
臺大學術典藏 2021-10-14T02:45:47Z Benign prostatic enlargement is not associated with diabetes: A population-based study Chiu Y.L.; Kao S.; Lin H.C.; Liu S.P.; CHAO-YUAN HUANG
臺大學術典藏 2021-02-02T07:50:57Z An appendectomy increases the risk of rheumatoid arthritis: A five-year follow-up study Tzeng Y.-M.; Kao L.-T.; Kao S.; Lin H.-C.; Tsai M.-C.; Lee, Cha-Ze
臺大學術典藏 2021-02-02T07:50:55Z Healthcare service utilization for practicing physicians: A population-based study Chiu Y.-L.; Kao S.; Lin H.-C.; Tsai M.-C.; Lee, Cha-Ze
臺大學術典藏 2021-01-29T03:17:18Z Benign prostatic enlargement is not associated with diabetes: A population-based study Chiu Y.L.;Kao S.;Lin H.C.;Shih-Ping Liu;Huang C.Y.; Chiu Y.L.; Kao S.; Lin H.C.; SHIH-PING LIU; Huang C.Y.
臺大學術典藏 2020-05-25T07:35:14Z Activity and safety of AZD3759 in EGFR-mutant non-small-cell lung cancer with CNS metastases (BLOOM): a phase 1, open-label, dose-escalation and dose-expansion study Yang J.C.-H.; Yang Z; Overend P; Kao S; Goldman J.W; Su W.-C; Natale R; Rabbie S; Harrop B; John T; Kim H.R; Chia-Chi Lin; Kim T.M; Ahn J.-S; Lee J.S; Kim S.-W; Cho B.C; Kim D.-W; Ahn M.-J
臺大學術典藏 2020-05-25T07:35:09Z Impact of lorlatinib on patient-reported outcomes (PROs) in patients (Pts) with advanced ALK+ or ROS1+ non-small cell lung cancer (NSCLC) Peters S; Shaw A.T; Besse B; Felip E; Solomon B.J; Soo R.A; Bearz A; Gadgee S.M; Chia-Chi Lin; Kao S; Seto T; Masters E.T; Abbattista A; Clancy J.S; Thurm H; Reisman A; Camidge D.R.
臺大學術典藏 2020-05-25T07:35:07Z ALK resistance mutations and efficacy of lorlatinib in advanced anaplastic lymphoma kinase-positive non�Vsmall-cell lung cancer Shaw A.T; Solomon B.J; Besse B; Bauer T.M; Chia-Chi Lin; Soo R.A; Riely G.J; Ignatius Ou S.-H; Clancy J.S; Li S; Abbattista A; Thurm H; Satouchi M; Camidge D.R; Kao S; Chiari R; Gadgeel S.M; Felip E; Martini J.-F.
臺大學術典藏 2020-05-25T07:34:59Z Impact of lorlatinib on patient-reported outcomes in patients with advanced ALK-positive or ROS1-positive non-small cell lung cancer Peters S; Shaw A.T; Besse B; Felip E; Solomon B.J; Soo R.A; Bearz A; Gadgeel S.M; Chia-Chi Lin; Kao S; Seto T; Masters E.T; Abbattista A; Clancy J.S; Thurm H; Reisman A; Peltz G; Ross Camidge D.
中山醫學大學 2020 Significant associations between telomere length related genetic loci and cardio-metabolic components Wu, T; Weng, P; Kao, S; Wu, Y; Chen, L; Yen, M; Lee, Y; Tse, C; Liu, T; Chen, H; Lin, M
臺大學術典藏 2019 Lorlatinib in advanced ROS1-positive non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 1�V2 trial Ou S.-H.I.;Li S;Abbattista A;Peltz G;Martini J.-F;Thurm H;Clancy J.S;Bauer T.M;Chia-Chi Lin;Kao S;Soo R.A;Besse B;Riely G.J;Chiari R;Solomon B.J;Shaw A.T; Shaw A.T; Solomon B.J; Chiari R; Riely G.J; Besse B; Soo R.A; Kao S; Chia-Chi Lin; Bauer T.M; Clancy J.S; Thurm H; Martini J.-F; Peltz G; Abbattista A; Li S; Ou S.-H.I.
國立成功大學 2019 Angiotensin-converting enzyme inhibitors or angiotensin receptor blocker monotherapy retard deterioration of renal function in Taiwanese chronic kidney disease population Zheng, C.-M.;Wang, J.-Y.;Chen, T.-T.;Wu, Y.-C.;Wu, Y.-L.;Lin, H.-T.;Chiu, S.-P.;Chang, T.-J.;Zheng, J.-Q.;Chu, N.-F.;Lin, Y.-M.;Su, Su S.-L.;Lu, K.-C.;Chen, J.-S.;Sung, F.-C.;Lee, C.-T.;Yang, Yang Y.;Hwang, S.-J.;Wang, M.-C.;Hsu, Y.-H.;Chiou, H.-Y.;Kao, S.;Wu, M.-Y.;Lin, Y.-F.
國立成功大學 2018 Relationship between body mass index and renal function deterioration among the Taiwanese chronic kidney disease population Chang, T.-J.;Zheng, C.-M.;Wu, M.-Y.;Chen, T.-T.;Wu, Y.-C.;Wu, Y.-L.;Lin, H.-T.;Zheng, J.-Q.;Chu, N.-F.;Lin, Y.-M.;Su, Su S.-L.;Lu, K.-C.;Chen, J.-S.;Sung, F.-C.;Lee, C.-T.;Yang, Yang Y.;Hwang, S.-J.;Wang, M.-C.;Hsu, Y.-H.;Chiou, H.-Y.;Kao, S.;Lin, Y.-F.
臺大學術典藏 2017 Activity and safety of AZD3759 in EGFR-mutant non-small-cell lung cancer with CNS metastases (BLOOM): a phase 1, open-label, dose-escalation and dose-expansion study Ahn M.-J; Kim D.-W; Cho B.C; Kim S.-W; Lee J.S; Ahn J.-S; Kim T.M; Lin C.-C; Kim H.R; John T; Kao S; Goldman J.W; Su W.-C; Natale R; Rabbie S; Harrop B; Overend P; Yang Z; CHIH-HSIN YANG; Chih-Hsin Yang;Yang Z;Overend P;Harrop B;Rabbie S;Natale R;Su W.-C;Goldman J.W;Kao S;John T;Kim H.R;Lin C.-C;Kim T.M;Ahn J.-S;Lee J.S;Kim S.-W;Cho B.C;Kim D.-W;Ahn M.-J
國立成功大學 2017 Importance-performance analysis of personal health records in Taiwan: A web-based survey Rau, H.-H.;Wu, Y.-S.;Chu, Chu C.-M.;Wang, F.-C.;Hsu, M.-H.;Chang, Chang C.-W.;Chen, K.-H.;Lee, Y.-L.;Kao, S.;Chiu, Y.-L.;Wen, H.-C.;Fuad, A.;Hsu, C.-Y.;Chiu, H.-W.
國立成功大學 2017 Activity and safety of AZD3759 in EGFR-mutant non-small-cell lung cancer with CNS metastases (BLOOM): a phase 1, open-label, dose-escalation and dose-expansion study Ahn, M.-J.;Kim, D.-W.;Cho, B.C.;Kim, S.-W.;Lee, J.S.;Ahn, J.-S.;Kim, T.M.;Lin, C.-C.;Kim, H.R.;John, T.;Kao, S.;Goldman, J.W.;Su, W.-C.;Natale, R.;Rabbie, S.;Harrop, B.;Overend, P.;Yang, Z.;Yang, J.C.-H.
國立臺灣大學 2015 Benign prostatic enlargement is not associated with diabetes: a population-based study Chiu, Y. L.; Kao, S.; Lin, H. C.; Liu, S. P.; Huang, C. Y.; 黃昭淵; 劉詩彬
國立臺灣科技大學 2014 The evaluation of fire rescue capability from post-earthquake fires in Taipei, Taiwan Shang, S.;Su, C.;Huang, C.;Kao, S.;Wu, Y.;Lin, C.
國家衛生研究院 2013-12-20 Dietary diversity predicts type of medical expenditure in elders Lo, YT;Wahlqvist, ML;Chang, YH;Kao, S;Lee, MS
國家衛生研究院 2013-11 Estimates of expected years of life lost and lifetime direct medical costs for malignant pleural mesothelioma patients: Data from Taiwan and New South Wales, Australia Soeberg, MJ;Lee, LJ;Kao, S;Van Zandwijk, N;Chang, YY;Wang, JD
國家衛生研究院 2013-09 Dietary diversity predicts medical expenditures in Taiwanese elders Lee, MS;Lo, YT;Wahlqvist, ML;Chang, YH;Kao, S
臺北醫學大學 2013 Pregnancy outcomes of anti-hypertensives for women with chronic hypertension: a population-based study CY, Su;HC, Lin;HC, Cheng;AMF, Yen;YH, Chen;Kao, S
臺北醫學大學 2013 Pregnancy outcomes of anti-hypertensives for women with chronic hypertension: a population-based study Su, CY;Lin, HC;Cheng, HC;AMF, Yen;Chen, YH;Kao, S

Showing items 1-25 of 43  (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page